Xylem SG&A decreased by 2.9% to $472.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $460.00M to $472.00M. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 13.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $304.00M | $273.00M | $301.00M | $304.00M | $314.00M | $294.00M | $315.00M | $354.00M | $446.00M | $491.00M | $466.00M | $474.00M | $485.00M | $445.00M | $507.00M | $460.00M | $503.00M | $474.00M | $486.00M | $472.00M |
| QoQ Change | — | -10.2% | +10.3% | +1.0% | +3.3% | -6.4% | +7.1% | +12.4% | +26.0% | +10.1% | -5.1% | +1.7% | +2.3% | -8.2% | +13.9% | -9.3% | +9.3% | -5.8% | +2.5% | -2.9% |
| YoY Change | — | — | — | — | +3.3% | +7.7% | +4.7% | +16.4% | +42.0% | +67.0% | +47.9% | +33.9% | +8.7% | -9.4% | +8.8% | -3.0% | +3.7% | +6.5% | -4.1% | +2.6% |